论文部分内容阅读
临床上对于肿瘤患者自体血液回收技术的研究,虽有徘徊,但一直谨慎而又坚定的向前发展;最近越来越多的证据显示,肿瘤手术中回收的自体回收血质量可能优于储存库血。采用简单的方法便能去除回收血液内的肿瘤细胞,如使用改良的白细胞滤器,即可进一步提高回收血液质量和安全性;因此目前仍需要进一步研究而获得改善患者预后的确凿证据,但自体血液回收的确为改善肿瘤患者手术预后提供了1个可行的方向。
Clinically, the study of autologous blood collection technology for cancer patients has been cautiously and steadily progressing despite the hovering. Recently, more and more evidences show that the quality of autologous blood collected during tumor surgery may be superior to that of the reservoir blood. Using a simple method to remove the recovered blood of tumor cells, such as the use of improved leukocyte filter, you can further improve the quality and safety of recovered blood; so there is still a need for further study to obtain the evidence to improve the prognosis of patients, but the autologous blood Recycling has indeed provided a feasible direction for improving the prognosis of patients with cancer.